Overview
Collagen Type II is the primary structural protein of articular cartilage, constituting the major fibrillar component of the cartilaginous ECM. Unlike Types I and III, it is rarely consumed as a hydrolysate for general skin support. Instead, Type II collagen is studied in two distinct forms: hydrolyzed (for cartilage amino acid supply) and undenatured (UC-II, which preserves native triple-helix epitopes). UC-II at low doses induces oral tolerance — a gut-mediated immune re-education that reduces autoimmune cartilage attack in arthritis.
Mechanism of action
Undenatured Type II collagen (UC-II) at microgram doses interacts with Peyer's patches in the gut-associated lymphoid tissue. This triggers induction of regulatory T cells (Tregs) that specifically recognize Type II collagen epitopes. When these Tregs encounter Type II collagen in joint cartilage, they secrete anti-inflammatory cytokines (TGF-β, IL-4, IL-10) that suppress local immune-mediated cartilage destruction. This oral tolerance mechanism is distinct from the amino acid supplementation approach used with hydrolyzed collagen, requiring far lower doses and native epitope preservation.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| joint health / oral tolerance (UC-II, undenatured) | oral | 40–40 mg | once daily (on empty stomach) | UC-II oral tolerance requires very low doses — 40 mg/day is the established effective dose. Higher doses may defeat the oral tolerance mechanism. |
| joint support (hydrolyzed collagen type II) | oral | 5000–10000 mg | once daily | Hydrolyzed form used at higher doses for amino acid supply; different mechanism from UC-II. |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
A landmark 1993 Science paper demonstrated that oral UC-II administration suppressed rheumatoid arthritis symptoms in a human trial (n=60). Subsequent animal and human studies confirm UC-II reduces osteoarthritis pain, improves joint function, and decreases inflammatory cytokines. A 2025 Annals of Medicine review consolidates current evidence for knee OA. Hydrolyzed Type II collagen supplements have also shown benefits in joint pain reduction in multiple RCTs, through a different (amino acid supply) mechanism.
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Collagen Type II for synergistic effects.
Legal status
Available OTC as a dietary supplement (both UC-II and hydrolyzed forms). UC-II is a patented ingredient. Not regulated as a pharmaceutical.
Where to get it
Verified directory — coming soon
PeptaHub is building a verified supplier directory with third-party testing data, compliance status, and reader ratings.